Research output per year
Research output per year
Personal profile
Side activities
Board activities
- Leukaemia UK grant panel (since 2016)
- Blood Cancer UK grant panel (since 2023)
- Blood Editorial Board (since 2024)
Commercial activities (personal remuneration)
- Acerta: seminar speaker (2023)
- Epistem (Manchester): revenues from licensed cell lines
- Roche: research support since 2022
- Syndax: research support 2021 – 2022
- ITCC-P4: scientific advisor since 2023
Memberships
- ASH
- EHA
- ITCC
External positions
PI - Research funding - Roche
18 Nov 2024 → 31 Dec 3999
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
PROTAC-Mediated GSPT1 Degradation Impairs the Expression of Fusion Genes in Acute Myeloid Leukemia
Perzolli, A., Steinebach, C., Krönke, J., Gütschow, M., Zwaan, C. M., Barneh, F. & Heidenreich, O., Jan 2025, In: Cancers. 17, 2, 16 p., 211.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia
Koedijk, J. B., van der Werf, I., Penter, L., Vermeulen, M. A., Barneh, F., Perzolli, A., Meesters-Ensing, J. I., Metselaar, D. S., Margaritis, T., Fiocco, M., de Groot-Kruseman, H. A., Moeniralam, R., Bang Christensen, K., Porter, B., Pfaff, K., Garcia, J. S., Rodig, S. J., Wu, C. J., Hasle, H. & Nierkens, S. & 3 others, , Nov 2024, In: Leukemia. 38, 11, p. 2332-2343 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
Lo Presti, V., Meringa, A., Dunnebach, E., van Velzen, A., Moreira, A. V., Stam, R. W., Kotecha, R. S., Krippner-Heidenreich, A., Heidenreich, O. T., Plantinga, M., Cornel, A., Sebestyen, Z., Kuball, J., van Til, N. P. & Nierkens, S., 5 Apr 2024, In: Journal for ImmunoTherapy of Cancer. 12, 4, 15 p., e008174.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile21 Downloads (Pure) -
NUP98 oncofusions in myeloid malignancies: An update on molecular mechanisms and therapeutic opportunities
Rasouli, M., Troester, S., Grebien, F., Goemans, B. F., Zwaan, C. M. & Heidenreich, O., Sept 2024, In: Hemasphere. 8, 9, 16 p., e70013.Research output: Contribution to journal › Review article › peer-review
Open AccessFile1 Downloads (Pure) -
Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia
Barneh, F., Koedijk, J. B., Wijnen, N. E., Meulendijks, T., Ashtiani, M., Dunnebach, E., Dautzenberg, N., Cornel, A. M., Krippner-Heidenreich, A., Klein, K., Zwaan, M. C., Kuball, J., Nierkens, S., Cloos, J., Kaspers, G. J. L. & Heidenreich, O., 1 Dec 2024, In: Haematologica. 109, 12, p. 4131-4136 6 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure)